An Examination of the Hybrid Mechanism of Action and
the Benefits of the BASHIR™ Endovascular Catheter
Courtesy of American Venous Forum
Dr. Anthony Comerota examines the unique hybrid mechanism of action and benefits of the BASHIR™ Endovascular Catheter. The BASHIR™ Endovascular Catheter leverages the synergistic effect of endogenous and exogenous lytics to optimize clot lysis through an expanding nitinol infusion basket that fissures the thrombus. This increases the surface area of the clot being exposed to the delivery of lytics.
See how this hybrid catheter employs both mechanical and pharmacomechanical methods to enable a more efficient, safe, and fast resolution of a clot.
Anthony J. Comerota, MD, FACS, FACC
